NexImmune (NEXI) Stock Statistics & Valuation Metrics

NexImmune has a market cap or net worth of $139.00. The enterprise value is $1.37.

NexImmune has 1,394,671 shares outstanding. The number of shares has decreased by -2.65% in one year.

NexImmune’s return on equity (ROE) is -9.22 and return on invested capital (ROIC) is -800.38%.

The current PE Ratio of NexImmune is ―. NexImmune’s PEG ratio is 0.00068.

In the last 12 months, NexImmune had revenue of 0.00 and earned -32.34M in profits. Earnings per share was -30.82.

In the last 12 months, operating cash flow was -17.61M and capital expenditures -48.67M, giving a free cash flow of -66.28M billion.

NexImmune pays an annual dividend of ―, resulting in a dividend yield of ―

NexImmune upcoming earnings date is Aug 7, 2024, After Close (Not Confirmed).

NexImmune as a current ratio of 1.06, with Debt / Equity ratio of 1.96%

In the past 12 months, NexImmune has paid 0.00 in taxes.

NexImmune EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.03.

NexImmune has $2.42M in cash and marketable securities with $0.00 in debt, giving a net cash position of $2.42M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for NexImmune is ―, which is 11.43% higher than the current price. The consensus rating is Hold